The role of CTGF in the diabetic rat retina and its relationship with VEGF and TGF-β2, elucidated by treatment with CTGFsiRNA

Acta Ophthalmologica

Volumn 88, Issue 6, 2010, Pages 652-659

  Yang, Hongwei ^a   Huang, Yonggang ^b   Chen, Xiaolong ^a   Liu, Jie ^a   Lu, Yan ^a   Bu, Limin ^a   Xia, Likun ^a   Xiao, Wei ^a   Chen, Ming ^a   Nie, Qingzhu ^a   Liu, Zheli ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b NORTHEASTERN UNIVERSITY   (China)

Author keywords

apoptosis; connective tissue growth factor (CTGF); diabetic retinopathy; rat; small interfering RNA

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA2; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETIC RETINOPATHY; DRUG ACTIVITY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; STREPTOZOCIN DIABETES; TISSUE LEVEL;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CONNECTIVE TISSUE GROWTH FACTOR; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; GENE EXPRESSION REGULATION; GENE SILENCING; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTRAVITREAL INJECTIONS; MALE; RATS; RATS, WISTAR; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA2; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77956209249     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01641.x     Document Type: Article

References (43)

1. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL Klein R (1998 Diabetic retinopathy. Diabetes Care 21 : 143 156.
2. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A Lorenzi M (2003 A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 52 : 506 511.
3. 3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 19 : 2958 2966.
4. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG Gardner TW (1998 Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J Clin Invest 102 : 783 791.
5. Barber AJ, Antonetti DA, Kern TS et al. (2005 The Ins-Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 46 : 2210 2218.
6. Blom IE, Goldschmeding R Leask A (2002 Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol 21 : 473 482.
7. Boulton M, Foreman D, Williams G McLeod D (1998 VEGF localization in diabetic retinopathy. Br J Ophthalmol 82 : 561 568.
8. Cai J Boulton M (2002 The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye 16 : 242 260.
9. Fan WH Karnovsky MJ (2000 Activation of protein kinase C inhibits the expression of connective tissue growth factor. Biochem Biophys Res Commun 275 : 312 321.
10. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE Mello CC (1998 Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 : 806 811.
11. Frazier K, Williams S, Kothapalli D, Klapper H Grotendorst GR (1996 Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107 : 404 411.
12. Fuchshofer R, Birke M, Welge-Lussen U, Kook D Lütjen-Drecoll E (2005 Transforming growth factor-β2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes. Invest Ophthalmol Vis Sci 46 : 568 578.
13. Gastinger MJ, Singh RS Barber AJ (2006 Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita diabetic mouse retinas. Invest Ophthalmol Vis Sci 47 : 3143 3150.
14. Hishikawa K, Nakaki T, Hirahashi J, Marumo T Saruta T (1995 Tranilast inhibits the effects of platelet-derived growth factor on cell proliferation and induction of nitric oxide. Eur J Pharmacol 291 : 435 438.
15. Hishikawa K, Oemar BS Nakaki T (2001 Static pressure regulates connective tissue growth factor expression in human mesangial cells. J Biol Chem 276 : 16797 16803.
16. Hughes JM, Kuiper EJ, Klaassen I et al. (2007 Advanced glycation endproducts cause increased CCN family and extracellular gene expression in the diabetic rodent retina. Diabetologia 50 : 1089 1098.
17. Kawata Y, Fujii Z, Sakumura T, Kitano M, Suzuki N Matsuzaki M (1998 High pressure conditions promote the proliferation of rat cultured mesangial cells in vitro. Biochim Biophys Acta 1401 : 195 202.
18. Kim B, Tang Q, Biswas PS et al. (2004 Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am J Pathol 165 : 2177 2185.
19. 2 and connective tissue growth factor in proliferative vitreoretinal diseases, possible involvement of hyalocytes and therapeutic potential of rho kinase inhibitor. Diabetes 56 : 231 238.
20. Kuiper EJ, Hughes JM, Van Geest RJ, Vogels IM, Goldschmeding R, Van Noorden CJ, Schlingemann RO Klaassen I (2007 Effect of VEGF-α on expression of profibrotic growth factor and extracellular matrix genes in the retina. Invest Ophthalmol Vis Sci 48 : 4267 4276.
21. Kusner LL, Sarthy VP Mohr S (2004 Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Müller cells. Invest Ophthalmol Vis Sci 45 : 1553 1561.
22. 1 in human umbilical vein endothelial cells. J Biol Chem 277 : 46248 46255.
23. Lorenzi M Gerhardinger C (2001 Early cellular and molecular changes induced by diabetes in the retina. Diabetologia 44 : 791 804.
24. Lu M Adamis AP (2002 Vascular endothelial growth factor gene regulation and action in diabetic retinopathy. Ophthalmol Clin North Am 15 : 69 79.
25. Martin PM, Roon P, Van Ells TK, Ganapathy V Smith SB (2004 Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45 : 3330 3336.
26. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F Brady HR (1999 Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 274 : 5830 5834.
27. Osicka TM, Yu Y, Lee V, Panagiotopoulos S, Kemp BE Jerums G (2001 Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery. Clin Sci 100 : 249 257.
28. Park SH, Park JW, Park SJ, Kim KY, Chung JW, Chun MH Oh SJ (2003 Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia 46 : 1260 1268.
29. Reich SJ, Fosnot J, Kuroki A, Tang W, Yang X, Maguire AM, Bennett J Tolentino MJ (2003 Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis 9 : 210 216.
30. Ruperez M, Lorenzo O, Blanco-Colio LM, Esteban V, Egido J Ruiz-Ortega M (2003 Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation 108 : 1499 1505.
31. Shimo T, Nakanishi T, Nishida T et al. (1999 Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem 126 : 137 145.
32. Shimo T, Kubota S, Kondo S, Nakanishi T, Sasaki A, Mese H, Matsumura T Takigawa M (2001 Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Lett 174 : 57 64.
33. Suzuma K, Naruse K, Suzuma I, Takahara N, Ueki K, Aiello LP King GL (2000 Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathway in retinal vascular cells. J Biol Chem 275 : 40725 40731.
34. Tikellis C, Cooper ME, Twigg SM, Burns WC Tolcos M (2004 Connective tissue growth factor is upregulated in the diabetic retina: amelioration by angiotensin-converting enzyme inhibition. Endocrinology 145 : 860 866.
35. Twigg SM Cooper ME (2004 The time has come to target connective tissue growth factor in diabetic complications. Diabetologia 47 : 965 968.
36. Van Nieuwenhoven FA, Jensen LJ, Flyvbjerg A Goldschmeding R (2005 Imbalance of growth factor signalling in diabetic kidney disease: is connective tissue growth factor (CTGF, CCN2) the perfect intervention point? Nephrol Dial Transplant 20 : 6 10.
37. Van Setten G, Berglin L, Blalock TD Schultz G (2005 Detection of connective tissue growth factor in subretinal fluid following retinal detachment: possible contribution to subretinal scar formation, preliminary results. Ophthalmic Res 37 : 289 292.
38. Wada J, Makino H Kanwar YS (2002 Gene expression and identification of gene therapy targets in diabetic nephropathy. Kidney Int 61 (Suppl.) : 73 78.
39. Witmer AN, Blaauwgeers HG, Weich HA, Alitalo K, Vrensen GF Schlingemann RO (2002 Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Invest Ophthalmol Vis Sci 43 : 849 857.
40. Yokoi H, Mukoyama M, Nagae T et al. (2004 Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 15 : 1430 1440.
41. Zhou XD, Tan FK, Guo X, Wallis D, Milewicz DM, Xue S Arnett FC (2005 Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor in cultured normal human fibroblasts. Arthritis Rheum 52 : 57 61.
42. Zhou XD, Xiong MM, Tan FK, Guo XJ Arnett FC (2006 SPARC, an upstream regulator of connective tissue growth factor in response to transforming growth factor-β stimulation. Arthritis Rheum 54 : 3885 3889.
43. Zimmet P, Alberti KG Shaw J (2001 Global and societal implications of the diabetes epidemic. Nature 414 : 782 787.